Connect with us


By follow to the orders of the NGT UP Govt bans bursting of crackers in 13 districts.



The Uttar Pradesh state cabinet has decided to comply with the orders of the National Green Tribunal (NGT) regarding firecrackers on Diwali. This resolution has been opted by the administration with respect to the continuously deteriorating air quality across the state. While many cities have imposed a complete ban on firecrackers, Lucknow has so far banned only certain categories of firecrackers.

According to the Additional Chief Secretary (Home), “The NGT’s order is a detailed one and we will comply with it. The air quality is deteriorating and steps have to be taken to address the issue.” While Meerut has already imposed a ban on firecrackers, Lucknow has so far banned only certain categories of firecrackers.

So far only firecrackers banned in Lucknow are the most preferred ‘ladis’ or ‘chatai’ and other similar high decibel crackers. Joint Commissioner of Police also informed that, “Sale of only those crackers that are in compliance with the Supreme Court’s order would be allowed”.

The Lucknow district administration have marked certain sensitive regions in the city as ‘No Cracker Zones. These zones include hospitals, nursing homes, educational institutions, court and zoological gardens. All activities of bursting firecrackers in these areas is strictly prohibited. As per the NGT guidelines, on festivals like Diwali and Gurupurab, fireworks would be allowed only between 8 pm and 10 pm, while on Christmas and New Year’s Eve, fireworks may start from 11.55 pm and continue till 12.30 am.

Though the restrictions and ban on firecracker activities may dull the festivities and celebrations this Diwali, it is an effective step to reduce the towering levels of air pollution in the state. Citizens are requested to cooperate with the state and NGT guidelines, in order to celebrate a safe and happy Diwali.

Owing to the declining air quality all across the state, sale and use of firecrackers is now banned in Lucknow and 11 other districts in UP. These cities include- Kanpur, Muzaffarnagar, Agra, Varanasi, Meerut, Hapur, Moradabad, Greater Noida, Baghpat, Bulandshahr and NCR. The ban will be effective from the midnight of November 9 and will go on till the 30th of December. This decision comes after the state agreed to comply with the guidelines of the National Green Tribunal on Monday.

-With inputs from IANS


447 cases of adverse effect reported,Covid-19 vaccine given to 2,24,301 beneficiaries :Govt.



A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.

Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.

“Today being Sunday, only six states conducted vaccination drive and in 553 sessions a total of 17,072 beneficiaries were vaccinated,” he said.

The six states where the vaccination drive was carried out on Sunday are Andhra Pradesh, Arunachal Pradesh, Karnataka, Kerala, Manipur and Tamil Nadu, he added.

Agnani said a total of 2,24,301 beneficiaries have been vaccinated till January 17 as per provisional reports, adding that 2,07,229 of them received the jabs on day one of the drive.

“A total of 447 AEFI have been reported on January 16 and 17, out of which only three required hospitalisation. Most of the AEFI reported so far are minor like fever, headache, nausea,” he said.

He said a meeting was held with all states and union territories on Sunday to review the progress of the drive, identify bottlenecks and plan corrective actions.

Prime Minister Narendra Modi rolled out the world’s largest inoculation drive against COVID-19 on Saturday and said the two vaccines being deployed will ensure a “decisive victory” for India against the pandemic.

India has approved two vaccines—Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India—for emergency use in the country.

According to the government, the shots will be offered first to an estimated one crore healthcare workers and around two coror frontline workers, and then to persons above 50 years of age, followed by persons younger than 50 years of age with associated comorbidities. PTI

Continue Reading